Blockchain Registration Transaction Record

20Slash20's Eye Drink to be Showcased at Moody Capital Conference

20Slash20 presents The Eye Drink at Moody Capital Solutions 2026 conference. CEO Roger Wu to speak Sept. 9. Learn about this eye-health beverage.

This news matters because it highlights the growing intersection of health and technology, as screen usage continues to rise globally. 20Slash20's participation in the Moody Capital Solutions 2026 conference signals investor interest in functional beverages targeting eye health, a niche yet expanding market. For consumers, The Eye Drink offers a convenient solution to combat digital eye strain, which is becoming a common health concern. For investors, the conference presentation provides an opportunity to evaluate a disruptive product in the life sciences space. The company's proactive engagement with investors could pave the way for future growth and market penetration, potentially influencing the functional beverage industry and how we approach eye care in a screen-centric world.